622 related articles for article (PubMed ID: 24075889)
1. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
[TBL] [Abstract][Full Text] [Related]
2. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of linaclotide for patients with chronic constipation.
Lembo AJ; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; Jeglinski BI; Johnston JM
Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
[TBL] [Abstract][Full Text] [Related]
4. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
Chang L; Lacy BE; Moshiree B; Kassebaum A; Abel JL; Hanlon J; Bartolini W; Boinpally R; Bochenek W; Fox SM; Mallick M; Tripp K; Omniewski N; Shea E; Borgstein N
Am J Gastroenterol; 2021 Sep; 116(9):1929-1937. PubMed ID: 34465695
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: linaclotide vs placebo-a study of bi-directional gut and brain axis.
Rao SSC; Xiang X; Yan Y; Rattanakovit K; Patcharatrakul T; Parr R; Ayyala D; Sharma A
Aliment Pharmacol Ther; 2020 Jun; 51(12):1332-1341. PubMed ID: 32406112
[TBL] [Abstract][Full Text] [Related]
7. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan.
Fukudo S; Miwa H; Nakajima A; Haruma K; Kosako M; Nakagawa A; Akiho H; Yamaguchi Y; Johnston JM; Currie M; Kinoshita Y
Neurogastroenterol Motil; 2018 Dec; 30(12):e13444. PubMed ID: 30136447
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological and clinical profile of linaclotide (Linzess
Keto Y; Kosako M
Nihon Yakurigaku Zasshi; 2019; 153(6):289-298. PubMed ID: 31178535
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study.
Fukudo S; Miwa H; Nakajima A; Kinoshita Y; Kosako M; Nakagawa A; Akiho H; Kuroishi K; Johnston JM; Currie M; Ohkusa T
Neurogastroenterol Motil; 2018 Dec; 30(12):e13442. PubMed ID: 30084233
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
13. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
Tegaserod Clinical Research Group
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
[TBL] [Abstract][Full Text] [Related]
14. Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and tertiary centres: the Alpine study.
Pohl D; Fried M; Lawrance D; Beck E; Hammer HF
BMJ Open; 2019 Dec; 9(12):e025627. PubMed ID: 31892640
[TBL] [Abstract][Full Text] [Related]
15. Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
Chey WD; Sayuk GS; Bartolini W; Reasner DS; Fox SM; Bochenek W; Boinpally R; Shea E; Tripp K; Borgstein N
Am J Gastroenterol; 2021 Feb; 116(2):354-361. PubMed ID: 33065589
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
Drossman DA; Chey WD; Johanson JF; Fass R; Scott C; Panas R; Ueno R
Aliment Pharmacol Ther; 2009 Feb; 29(3):329-41. PubMed ID: 19006537
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.
Rey E; Mearin F; Alcedo J; Ciriza C; Delgado-Aros S; Freitas T; Mascarenhas M; Mínguez M; Santos J; Serra J
Adv Ther; 2017 Mar; 34(3):587-598. PubMed ID: 28083815
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
Shah ED; Kim HM; Schoenfeld P
Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
Tack J; Müller-Lissner S; Bytzer P; Corinaldesi R; Chang L; Viegas A; Schnekenbuehl S; Dunger-Baldauf C; Rueegg P
Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
[TBL] [Abstract][Full Text] [Related]
20. Pilot study on the effect of linaclotide in patients with chronic constipation.
Johnston JM; Kurtz CB; Drossman DA; Lembo AJ; Jeglinski BI; MacDougall JE; Antonelli SM; Currie MG
Am J Gastroenterol; 2009 Jan; 104(1):125-32. PubMed ID: 19098860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
